A Single Centre Experience with Pre-Operative Markers in the Prediction of Outcomes after Liver Resection for Hepatocellular Carcinoma
-
Published:2023-04-24
Issue:7
Volume:27
Page:1376-1386
-
ISSN:1091-255X
-
Container-title:Journal of Gastrointestinal Surgery
-
language:en
-
Short-container-title:J Gastrointest Surg
Author:
Peri Varun, Lee Eunice, Fink Michael, Starkey Graham, Nikfarjam Mehrdad, Yoshino Osamu, Furtado Ruelan, Sinclair Marie, Testro Adam, Majumdar Avik, Jones Robert, Muralidharan Vijayaragavan, Perini Marcos ViniciusORCID
Subject
Gastroenterology,Surgery
Reference50 articles.
1. Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1. 2. Wallace MC, Preen DB, Short MW, Adams LA, Jeffrey GP. Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival. Liver Int. 2019;39(3):522-30. 3. Carville KS, MacLachlan JH, Thursfield V, Cowie BC. Hepatocellular carcinoma over three decades in Victoria, Australia: epidemiology, diagnosis and trends, 1984–2013. Internal medicine journal. 2018;48(7):835-44. 4. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nature Reviews Disease Primers. 2021;7(1):6. 5. Korean Liver Cancer A, National Cancer C. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver. 2019;13(3):227–99.
|
|